KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 14 days ( 0 % )
Last Price $4.92 0 %
High/ Low $4.92 - $4.92 0%
Chg 7 Days N/A $4.92 $4.92
Chg 30 Days N/A $4.92 $4.92
Chg 12 mos -19.21 % $6.09 $4.92
Trend - 3 mos -4.08 % Width: 5.86 %
Trend - 12 mos -18.51 % Width: 107.25 %
Pred. range - 3 mos $4.57 - $4.84 -7.13 % - -1.69 %
Pred. range - 12 mos $2.29 - $4.74 -53.47 % - -3.57 %
Short MA avg 3 mos Buy Jul 12, 2019 - 50 days
Long MA avg 3 mos Buy Sep 03, 2019 - 14 days
Short/Long MA avg 3 mos Buy Sep 03, 2019 - 14 days
Short MA avg 12 mos Sell Jul 05, 2019 - 55 days
Long MA avg 12 mos Buy Apr 25, 2019 - 104 days
Short/Long MA avg 12 mos Buy May 08, 2019 - 95 days
Pivot Short Buy Jul 17, 2019 - 47 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Aratana Therapeutics

Aratana Therapeutics Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of biopharmaceutical products for the companion animals worldwide. Its product portfolio includes various therapeutic candidates consisting of small molecule pharmaceuticals and large molecule biologics that target various opportunities in serious medical conditions in pets. The company develops AT-001, a prostag... PETX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT